Sunshine Biopharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $9,263 | $8,088 | $8,577 | $9,417 |
Gross Profit | 2,426 | 2,104 | 3,028 | 3,073 |
EBITDA | -1,534 | -1,167 | -925 | |
EBIT | -1,612 | -1,243 | -1,021 | |
Net Income | -1,564 | -1,243 | -2,140 | -883 |
Net Change In Cash | 9,263 | 8,088 | 8,577 | 9,417 |
Free Cash Flow | -912 | -2,077 | -1,655 | -761 |
Cash | 13,748 | 6,913 | 9,123 | 9,306 |
Basic Shares | 1,365 | 490 | 490 | 465 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $36,305 | $34,874 | $24,092 | $4,345 |
Gross Profit | 11,923 | 10,669 | 8,339 | 1,696 |
EBITDA | -5,621 | -5,136 | -3,824 | -26,446 |
EBIT | -5,953 | -5,360 | -3,973 | -26,471 |
Net Income | -5,975 | -5,134 | -4,506 | -26,744 |
Net Change In Cash | 36,305 | 34,874 | 24,092 | 4,345 |
Free Cash Flow | -5,505 | -14,852 | -9,563 | -5,553 |
Cash | 9,123 | 9,686 | 16,292 | 21,826 |
Basic Shares | 415 | 70 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.15 |
2026-03-31 | -$2.50 |
2025-12-31 | -$0.46 |
2025-09-30 | -$1.90 |